Biotech and pharma leaders are invited to join CMIC for an exclusive in-person lunch and networking event focused on expanding drug development into Japan and the broader Asia-Pacific (APAC) region.
Learn how Japan serves as a strategic gateway to high-value APAC markets — South Korea, Australia, Taiwan, and Southeast Asia — and how to advance clinical development through local expertise.
The program will conclude with an interactive panel discussion and Q&A.
Register for the lunch and learn here: https://en.cmicgroup.com/massbio_2026_eventregistration/
- Please note: Submitting the form does not guarantee admission. Due to limited capacity, your registration will be confirmed only after you receive a confirmation email with your official event ticket.
Agenda:
| Time (EST) | Session | Speaker(s) |
| 11:00 – 11:30 AM | Registration & Networking | |
| 11:30 – 11:40 AM | Welcome & Opening Remarks | Keiko Oishi, CMIC Group |
| 11:40 – 12:05 PM | Presentation: Clinical Trial Landscape in Japan & APAC | Kento Nakamura, CMIC Group |
| 12:05 – 12:30 PM | Presentation: Overview of the Japan Agency for Medical Research and Development (AMED) | Masafumi Sato, Director, Washington DC Office, AMED |
| 12:30 – 1:30 PM | Interactive Panel Discussion | Kento Nakamura, CMIC Group
Rita Amirana, Alnylam Pharmaceuticals Sean Cao, NovaBridge Biosciences Wakako Toga, National Cancer Center Japan |
| 1:30 – 1:45 PM | Closing & Networking |
